Global PD-1 and PD-L1 Drug Supply, Demand and Key Producers, 2023-2029
The global PD-1 and PD-L1 Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
PD-1/PD-L1 is an important part of the human immune system-a drug target on T cells. Drugs designed for this target can activate the immune effect of T cells on tumor cells, thereby awakening the patient's own anti-cancer effect. tumor effect.
This report studies the global PD-1 and PD-L1 Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PD-1 and PD-L1 Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of PD-1 and PD-L1 Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PD-1 and PD-L1 Drug total production and demand, 2018-2029, (K Units)
Global PD-1 and PD-L1 Drug total production value, 2018-2029, (USD Million)
Global PD-1 and PD-L1 Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global PD-1 and PD-L1 Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: PD-1 and PD-L1 Drug domestic production, consumption, key domestic manufacturers and share
Global PD-1 and PD-L1 Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global PD-1 and PD-L1 Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global PD-1 and PD-L1 Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global PD-1 and PD-L1 Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol Myers Squibb, Merck & Co., Inc., F. Hoffmann -La Roche Ltd, AstraZeneca, Sanofi, Pfizer Inc, Lilly, Novartis AG and GSK, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PD-1 and PD-L1 Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global PD-1 and PD-L1 Drug Market, By Region:
1. How big is the global PD-1 and PD-L1 Drug market?
2. What is the demand of the global PD-1 and PD-L1 Drug market?
3. What is the year over year growth of the global PD-1 and PD-L1 Drug market?
4. What is the production and production value of the global PD-1 and PD-L1 Drug market?
5. Who are the key producers in the global PD-1 and PD-L1 Drug market?
6. What are the growth factors driving the market demand?
PD-1/PD-L1 is an important part of the human immune system-a drug target on T cells. Drugs designed for this target can activate the immune effect of T cells on tumor cells, thereby awakening the patient's own anti-cancer effect. tumor effect.
This report studies the global PD-1 and PD-L1 Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PD-1 and PD-L1 Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of PD-1 and PD-L1 Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PD-1 and PD-L1 Drug total production and demand, 2018-2029, (K Units)
Global PD-1 and PD-L1 Drug total production value, 2018-2029, (USD Million)
Global PD-1 and PD-L1 Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global PD-1 and PD-L1 Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: PD-1 and PD-L1 Drug domestic production, consumption, key domestic manufacturers and share
Global PD-1 and PD-L1 Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global PD-1 and PD-L1 Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global PD-1 and PD-L1 Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global PD-1 and PD-L1 Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol Myers Squibb, Merck & Co., Inc., F. Hoffmann -La Roche Ltd, AstraZeneca, Sanofi, Pfizer Inc, Lilly, Novartis AG and GSK, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PD-1 and PD-L1 Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global PD-1 and PD-L1 Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- PD-1 Monoclonal Antibody
- PD-L1 Monoclonal Antibody
- Liver Cancer
- Esophageal Cancer
- Nasal Cancer
- Stomach Cancer
- Other
- Bristol Myers Squibb
- Merck & Co., Inc.
- F. Hoffmann -La Roche Ltd
- AstraZeneca
- Sanofi
- Pfizer Inc
- Lilly
- Novartis AG
- GSK
- Junshi Biosciences
- Akeso, Inc
- BeiGene
- Innovent
- Jiangsu Hengrui Medicine Co.,Ltd
- Cstone
- Henlius
- Simcere Pharmaceutical Group Limited
1. How big is the global PD-1 and PD-L1 Drug market?
2. What is the demand of the global PD-1 and PD-L1 Drug market?
3. What is the year over year growth of the global PD-1 and PD-L1 Drug market?
4. What is the production and production value of the global PD-1 and PD-L1 Drug market?
5. Who are the key producers in the global PD-1 and PD-L1 Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 PD-1 and PD-L1 Drug Introduction
1.2 World PD-1 and PD-L1 Drug Supply & Forecast
1.2.1 World PD-1 and PD-L1 Drug Production Value (2018 & 2022 & 2029)
1.2.2 World PD-1 and PD-L1 Drug Production (2018-2029)
1.2.3 World PD-1 and PD-L1 Drug Pricing Trends (2018-2029)
1.3 World PD-1 and PD-L1 Drug Production by Region (Based on Production Site)
1.3.1 World PD-1 and PD-L1 Drug Production Value by Region (2018-2029)
1.3.2 World PD-1 and PD-L1 Drug Production by Region (2018-2029)
1.3.3 World PD-1 and PD-L1 Drug Average Price by Region (2018-2029)
1.3.4 North America PD-1 and PD-L1 Drug Production (2018-2029)
1.3.5 Europe PD-1 and PD-L1 Drug Production (2018-2029)
1.3.6 China PD-1 and PD-L1 Drug Production (2018-2029)
1.3.7 Japan PD-1 and PD-L1 Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 PD-1 and PD-L1 Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PD-1 and PD-L1 Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World PD-1 and PD-L1 Drug Demand (2018-2029)
2.2 World PD-1 and PD-L1 Drug Consumption by Region
2.2.1 World PD-1 and PD-L1 Drug Consumption by Region (2018-2023)
2.2.2 World PD-1 and PD-L1 Drug Consumption Forecast by Region (2024-2029)
2.3 United States PD-1 and PD-L1 Drug Consumption (2018-2029)
2.4 China PD-1 and PD-L1 Drug Consumption (2018-2029)
2.5 Europe PD-1 and PD-L1 Drug Consumption (2018-2029)
2.6 Japan PD-1 and PD-L1 Drug Consumption (2018-2029)
2.7 South Korea PD-1 and PD-L1 Drug Consumption (2018-2029)
2.8 ASEAN PD-1 and PD-L1 Drug Consumption (2018-2029)
2.9 India PD-1 and PD-L1 Drug Consumption (2018-2029)
3 WORLD PD-1 AND PD-L1 DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PD-1 and PD-L1 Drug Production Value by Manufacturer (2018-2023)
3.2 World PD-1 and PD-L1 Drug Production by Manufacturer (2018-2023)
3.3 World PD-1 and PD-L1 Drug Average Price by Manufacturer (2018-2023)
3.4 PD-1 and PD-L1 Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PD-1 and PD-L1 Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PD-1 and PD-L1 Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for PD-1 and PD-L1 Drug in 2022
3.6 PD-1 and PD-L1 Drug Market: Overall Company Footprint Analysis
3.6.1 PD-1 and PD-L1 Drug Market: Region Footprint
3.6.2 PD-1 and PD-L1 Drug Market: Company Product Type Footprint
3.6.3 PD-1 and PD-L1 Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PD-1 and PD-L1 Drug Production Value Comparison
4.1.1 United States VS China: PD-1 and PD-L1 Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: PD-1 and PD-L1 Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: PD-1 and PD-L1 Drug Production Comparison
4.2.1 United States VS China: PD-1 and PD-L1 Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: PD-1 and PD-L1 Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: PD-1 and PD-L1 Drug Consumption Comparison
4.3.1 United States VS China: PD-1 and PD-L1 Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: PD-1 and PD-L1 Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based PD-1 and PD-L1 Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based PD-1 and PD-L1 Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PD-1 and PD-L1 Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers PD-1 and PD-L1 Drug Production (2018-2023)
4.5 China Based PD-1 and PD-L1 Drug Manufacturers and Market Share
4.5.1 China Based PD-1 and PD-L1 Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PD-1 and PD-L1 Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers PD-1 and PD-L1 Drug Production (2018-2023)
4.6 Rest of World Based PD-1 and PD-L1 Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based PD-1 and PD-L1 Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PD-1 and PD-L1 Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers PD-1 and PD-L1 Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World PD-1 and PD-L1 Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 PD-1 Monoclonal Antibody
5.2.2 PD-L1 Monoclonal Antibody
5.3 Market Segment by Type
5.3.1 World PD-1 and PD-L1 Drug Production by Type (2018-2029)
5.3.2 World PD-1 and PD-L1 Drug Production Value by Type (2018-2029)
5.3.3 World PD-1 and PD-L1 Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World PD-1 and PD-L1 Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Liver Cancer
6.2.2 Esophageal Cancer
6.2.3 Nasal Cancer
6.2.4 Stomach Cancer
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World PD-1 and PD-L1 Drug Production by Application (2018-2029)
6.3.2 World PD-1 and PD-L1 Drug Production Value by Application (2018-2029)
6.3.3 World PD-1 and PD-L1 Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Details
7.1.2 Bristol Myers Squibb Major Business
7.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Product and Services
7.1.4 Bristol Myers Squibb PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bristol Myers Squibb Recent Developments/Updates
7.1.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Details
7.2.2 Merck & Co., Inc. Major Business
7.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Product and Services
7.2.4 Merck & Co., Inc. PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck & Co., Inc. Recent Developments/Updates
7.2.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.3 F. Hoffmann -La Roche Ltd
7.3.1 F. Hoffmann -La Roche Ltd Details
7.3.2 F. Hoffmann -La Roche Ltd Major Business
7.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product and Services
7.3.4 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 F. Hoffmann -La Roche Ltd Recent Developments/Updates
7.3.6 F. Hoffmann -La Roche Ltd Competitive Strengths & Weaknesses
7.4 AstraZeneca
7.4.1 AstraZeneca Details
7.4.2 AstraZeneca Major Business
7.4.3 AstraZeneca PD-1 and PD-L1 Drug Product and Services
7.4.4 AstraZeneca PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 AstraZeneca Recent Developments/Updates
7.4.6 AstraZeneca Competitive Strengths & Weaknesses
7.5 Sanofi
7.5.1 Sanofi Details
7.5.2 Sanofi Major Business
7.5.3 Sanofi PD-1 and PD-L1 Drug Product and Services
7.5.4 Sanofi PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Recent Developments/Updates
7.5.6 Sanofi Competitive Strengths & Weaknesses
7.6 Pfizer Inc
7.6.1 Pfizer Inc Details
7.6.2 Pfizer Inc Major Business
7.6.3 Pfizer Inc PD-1 and PD-L1 Drug Product and Services
7.6.4 Pfizer Inc PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Pfizer Inc Recent Developments/Updates
7.6.6 Pfizer Inc Competitive Strengths & Weaknesses
7.7 Lilly
7.7.1 Lilly Details
7.7.2 Lilly Major Business
7.7.3 Lilly PD-1 and PD-L1 Drug Product and Services
7.7.4 Lilly PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Lilly Recent Developments/Updates
7.7.6 Lilly Competitive Strengths & Weaknesses
7.8 Novartis AG
7.8.1 Novartis AG Details
7.8.2 Novartis AG Major Business
7.8.3 Novartis AG PD-1 and PD-L1 Drug Product and Services
7.8.4 Novartis AG PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Novartis AG Recent Developments/Updates
7.8.6 Novartis AG Competitive Strengths & Weaknesses
7.9 GSK
7.9.1 GSK Details
7.9.2 GSK Major Business
7.9.3 GSK PD-1 and PD-L1 Drug Product and Services
7.9.4 GSK PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 GSK Recent Developments/Updates
7.9.6 GSK Competitive Strengths & Weaknesses
7.10 Junshi Biosciences
7.10.1 Junshi Biosciences Details
7.10.2 Junshi Biosciences Major Business
7.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Product and Services
7.10.4 Junshi Biosciences PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Junshi Biosciences Recent Developments/Updates
7.10.6 Junshi Biosciences Competitive Strengths & Weaknesses
7.11 Akeso, Inc
7.11.1 Akeso, Inc Details
7.11.2 Akeso, Inc Major Business
7.11.3 Akeso, Inc PD-1 and PD-L1 Drug Product and Services
7.11.4 Akeso, Inc PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Akeso, Inc Recent Developments/Updates
7.11.6 Akeso, Inc Competitive Strengths & Weaknesses
7.12 BeiGene
7.12.1 BeiGene Details
7.12.2 BeiGene Major Business
7.12.3 BeiGene PD-1 and PD-L1 Drug Product and Services
7.12.4 BeiGene PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 BeiGene Recent Developments/Updates
7.12.6 BeiGene Competitive Strengths & Weaknesses
7.13 Innovent
7.13.1 Innovent Details
7.13.2 Innovent Major Business
7.13.3 Innovent PD-1 and PD-L1 Drug Product and Services
7.13.4 Innovent PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Innovent Recent Developments/Updates
7.13.6 Innovent Competitive Strengths & Weaknesses
7.14 Jiangsu Hengrui Medicine Co.,Ltd
7.14.1 Jiangsu Hengrui Medicine Co.,Ltd Details
7.14.2 Jiangsu Hengrui Medicine Co.,Ltd Major Business
7.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product and Services
7.14.4 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Jiangsu Hengrui Medicine Co.,Ltd Recent Developments/Updates
7.14.6 Jiangsu Hengrui Medicine Co.,Ltd Competitive Strengths & Weaknesses
7.15 Cstone
7.15.1 Cstone Details
7.15.2 Cstone Major Business
7.15.3 Cstone PD-1 and PD-L1 Drug Product and Services
7.15.4 Cstone PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Cstone Recent Developments/Updates
7.15.6 Cstone Competitive Strengths & Weaknesses
7.16 Henlius
7.16.1 Henlius Details
7.16.2 Henlius Major Business
7.16.3 Henlius PD-1 and PD-L1 Drug Product and Services
7.16.4 Henlius PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Henlius Recent Developments/Updates
7.16.6 Henlius Competitive Strengths & Weaknesses
7.17 Simcere Pharmaceutical Group Limited
7.17.1 Simcere Pharmaceutical Group Limited Details
7.17.2 Simcere Pharmaceutical Group Limited Major Business
7.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product and Services
7.17.4 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Simcere Pharmaceutical Group Limited Recent Developments/Updates
7.17.6 Simcere Pharmaceutical Group Limited Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 PD-1 and PD-L1 Drug Industry Chain
8.2 PD-1 and PD-L1 Drug Upstream Analysis
8.2.1 PD-1 and PD-L1 Drug Core Raw Materials
8.2.2 Main Manufacturers of PD-1 and PD-L1 Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 PD-1 and PD-L1 Drug Production Mode
8.6 PD-1 and PD-L1 Drug Procurement Model
8.7 PD-1 and PD-L1 Drug Industry Sales Model and Sales Channels
8.7.1 PD-1 and PD-L1 Drug Sales Model
8.7.2 PD-1 and PD-L1 Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 PD-1 and PD-L1 Drug Introduction
1.2 World PD-1 and PD-L1 Drug Supply & Forecast
1.2.1 World PD-1 and PD-L1 Drug Production Value (2018 & 2022 & 2029)
1.2.2 World PD-1 and PD-L1 Drug Production (2018-2029)
1.2.3 World PD-1 and PD-L1 Drug Pricing Trends (2018-2029)
1.3 World PD-1 and PD-L1 Drug Production by Region (Based on Production Site)
1.3.1 World PD-1 and PD-L1 Drug Production Value by Region (2018-2029)
1.3.2 World PD-1 and PD-L1 Drug Production by Region (2018-2029)
1.3.3 World PD-1 and PD-L1 Drug Average Price by Region (2018-2029)
1.3.4 North America PD-1 and PD-L1 Drug Production (2018-2029)
1.3.5 Europe PD-1 and PD-L1 Drug Production (2018-2029)
1.3.6 China PD-1 and PD-L1 Drug Production (2018-2029)
1.3.7 Japan PD-1 and PD-L1 Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 PD-1 and PD-L1 Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PD-1 and PD-L1 Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World PD-1 and PD-L1 Drug Demand (2018-2029)
2.2 World PD-1 and PD-L1 Drug Consumption by Region
2.2.1 World PD-1 and PD-L1 Drug Consumption by Region (2018-2023)
2.2.2 World PD-1 and PD-L1 Drug Consumption Forecast by Region (2024-2029)
2.3 United States PD-1 and PD-L1 Drug Consumption (2018-2029)
2.4 China PD-1 and PD-L1 Drug Consumption (2018-2029)
2.5 Europe PD-1 and PD-L1 Drug Consumption (2018-2029)
2.6 Japan PD-1 and PD-L1 Drug Consumption (2018-2029)
2.7 South Korea PD-1 and PD-L1 Drug Consumption (2018-2029)
2.8 ASEAN PD-1 and PD-L1 Drug Consumption (2018-2029)
2.9 India PD-1 and PD-L1 Drug Consumption (2018-2029)
3 WORLD PD-1 AND PD-L1 DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PD-1 and PD-L1 Drug Production Value by Manufacturer (2018-2023)
3.2 World PD-1 and PD-L1 Drug Production by Manufacturer (2018-2023)
3.3 World PD-1 and PD-L1 Drug Average Price by Manufacturer (2018-2023)
3.4 PD-1 and PD-L1 Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PD-1 and PD-L1 Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PD-1 and PD-L1 Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for PD-1 and PD-L1 Drug in 2022
3.6 PD-1 and PD-L1 Drug Market: Overall Company Footprint Analysis
3.6.1 PD-1 and PD-L1 Drug Market: Region Footprint
3.6.2 PD-1 and PD-L1 Drug Market: Company Product Type Footprint
3.6.3 PD-1 and PD-L1 Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PD-1 and PD-L1 Drug Production Value Comparison
4.1.1 United States VS China: PD-1 and PD-L1 Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: PD-1 and PD-L1 Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: PD-1 and PD-L1 Drug Production Comparison
4.2.1 United States VS China: PD-1 and PD-L1 Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: PD-1 and PD-L1 Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: PD-1 and PD-L1 Drug Consumption Comparison
4.3.1 United States VS China: PD-1 and PD-L1 Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: PD-1 and PD-L1 Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based PD-1 and PD-L1 Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based PD-1 and PD-L1 Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PD-1 and PD-L1 Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers PD-1 and PD-L1 Drug Production (2018-2023)
4.5 China Based PD-1 and PD-L1 Drug Manufacturers and Market Share
4.5.1 China Based PD-1 and PD-L1 Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PD-1 and PD-L1 Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers PD-1 and PD-L1 Drug Production (2018-2023)
4.6 Rest of World Based PD-1 and PD-L1 Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based PD-1 and PD-L1 Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PD-1 and PD-L1 Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers PD-1 and PD-L1 Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World PD-1 and PD-L1 Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 PD-1 Monoclonal Antibody
5.2.2 PD-L1 Monoclonal Antibody
5.3 Market Segment by Type
5.3.1 World PD-1 and PD-L1 Drug Production by Type (2018-2029)
5.3.2 World PD-1 and PD-L1 Drug Production Value by Type (2018-2029)
5.3.3 World PD-1 and PD-L1 Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World PD-1 and PD-L1 Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Liver Cancer
6.2.2 Esophageal Cancer
6.2.3 Nasal Cancer
6.2.4 Stomach Cancer
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World PD-1 and PD-L1 Drug Production by Application (2018-2029)
6.3.2 World PD-1 and PD-L1 Drug Production Value by Application (2018-2029)
6.3.3 World PD-1 and PD-L1 Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Details
7.1.2 Bristol Myers Squibb Major Business
7.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Product and Services
7.1.4 Bristol Myers Squibb PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bristol Myers Squibb Recent Developments/Updates
7.1.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Details
7.2.2 Merck & Co., Inc. Major Business
7.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Product and Services
7.2.4 Merck & Co., Inc. PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck & Co., Inc. Recent Developments/Updates
7.2.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.3 F. Hoffmann -La Roche Ltd
7.3.1 F. Hoffmann -La Roche Ltd Details
7.3.2 F. Hoffmann -La Roche Ltd Major Business
7.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product and Services
7.3.4 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 F. Hoffmann -La Roche Ltd Recent Developments/Updates
7.3.6 F. Hoffmann -La Roche Ltd Competitive Strengths & Weaknesses
7.4 AstraZeneca
7.4.1 AstraZeneca Details
7.4.2 AstraZeneca Major Business
7.4.3 AstraZeneca PD-1 and PD-L1 Drug Product and Services
7.4.4 AstraZeneca PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 AstraZeneca Recent Developments/Updates
7.4.6 AstraZeneca Competitive Strengths & Weaknesses
7.5 Sanofi
7.5.1 Sanofi Details
7.5.2 Sanofi Major Business
7.5.3 Sanofi PD-1 and PD-L1 Drug Product and Services
7.5.4 Sanofi PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Recent Developments/Updates
7.5.6 Sanofi Competitive Strengths & Weaknesses
7.6 Pfizer Inc
7.6.1 Pfizer Inc Details
7.6.2 Pfizer Inc Major Business
7.6.3 Pfizer Inc PD-1 and PD-L1 Drug Product and Services
7.6.4 Pfizer Inc PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Pfizer Inc Recent Developments/Updates
7.6.6 Pfizer Inc Competitive Strengths & Weaknesses
7.7 Lilly
7.7.1 Lilly Details
7.7.2 Lilly Major Business
7.7.3 Lilly PD-1 and PD-L1 Drug Product and Services
7.7.4 Lilly PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Lilly Recent Developments/Updates
7.7.6 Lilly Competitive Strengths & Weaknesses
7.8 Novartis AG
7.8.1 Novartis AG Details
7.8.2 Novartis AG Major Business
7.8.3 Novartis AG PD-1 and PD-L1 Drug Product and Services
7.8.4 Novartis AG PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Novartis AG Recent Developments/Updates
7.8.6 Novartis AG Competitive Strengths & Weaknesses
7.9 GSK
7.9.1 GSK Details
7.9.2 GSK Major Business
7.9.3 GSK PD-1 and PD-L1 Drug Product and Services
7.9.4 GSK PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 GSK Recent Developments/Updates
7.9.6 GSK Competitive Strengths & Weaknesses
7.10 Junshi Biosciences
7.10.1 Junshi Biosciences Details
7.10.2 Junshi Biosciences Major Business
7.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Product and Services
7.10.4 Junshi Biosciences PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Junshi Biosciences Recent Developments/Updates
7.10.6 Junshi Biosciences Competitive Strengths & Weaknesses
7.11 Akeso, Inc
7.11.1 Akeso, Inc Details
7.11.2 Akeso, Inc Major Business
7.11.3 Akeso, Inc PD-1 and PD-L1 Drug Product and Services
7.11.4 Akeso, Inc PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Akeso, Inc Recent Developments/Updates
7.11.6 Akeso, Inc Competitive Strengths & Weaknesses
7.12 BeiGene
7.12.1 BeiGene Details
7.12.2 BeiGene Major Business
7.12.3 BeiGene PD-1 and PD-L1 Drug Product and Services
7.12.4 BeiGene PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 BeiGene Recent Developments/Updates
7.12.6 BeiGene Competitive Strengths & Weaknesses
7.13 Innovent
7.13.1 Innovent Details
7.13.2 Innovent Major Business
7.13.3 Innovent PD-1 and PD-L1 Drug Product and Services
7.13.4 Innovent PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Innovent Recent Developments/Updates
7.13.6 Innovent Competitive Strengths & Weaknesses
7.14 Jiangsu Hengrui Medicine Co.,Ltd
7.14.1 Jiangsu Hengrui Medicine Co.,Ltd Details
7.14.2 Jiangsu Hengrui Medicine Co.,Ltd Major Business
7.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product and Services
7.14.4 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Jiangsu Hengrui Medicine Co.,Ltd Recent Developments/Updates
7.14.6 Jiangsu Hengrui Medicine Co.,Ltd Competitive Strengths & Weaknesses
7.15 Cstone
7.15.1 Cstone Details
7.15.2 Cstone Major Business
7.15.3 Cstone PD-1 and PD-L1 Drug Product and Services
7.15.4 Cstone PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Cstone Recent Developments/Updates
7.15.6 Cstone Competitive Strengths & Weaknesses
7.16 Henlius
7.16.1 Henlius Details
7.16.2 Henlius Major Business
7.16.3 Henlius PD-1 and PD-L1 Drug Product and Services
7.16.4 Henlius PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Henlius Recent Developments/Updates
7.16.6 Henlius Competitive Strengths & Weaknesses
7.17 Simcere Pharmaceutical Group Limited
7.17.1 Simcere Pharmaceutical Group Limited Details
7.17.2 Simcere Pharmaceutical Group Limited Major Business
7.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product and Services
7.17.4 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Simcere Pharmaceutical Group Limited Recent Developments/Updates
7.17.6 Simcere Pharmaceutical Group Limited Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 PD-1 and PD-L1 Drug Industry Chain
8.2 PD-1 and PD-L1 Drug Upstream Analysis
8.2.1 PD-1 and PD-L1 Drug Core Raw Materials
8.2.2 Main Manufacturers of PD-1 and PD-L1 Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 PD-1 and PD-L1 Drug Production Mode
8.6 PD-1 and PD-L1 Drug Procurement Model
8.7 PD-1 and PD-L1 Drug Industry Sales Model and Sales Channels
8.7.1 PD-1 and PD-L1 Drug Sales Model
8.7.2 PD-1 and PD-L1 Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World PD-1 and PD-L1 Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World PD-1 and PD-L1 Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World PD-1 and PD-L1 Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World PD-1 and PD-L1 Drug Production Value Market Share by Region (2018-2023)
Table 5. World PD-1 and PD-L1 Drug Production Value Market Share by Region (2024-2029)
Table 6. World PD-1 and PD-L1 Drug Production by Region (2018-2023) & (K Units)
Table 7. World PD-1 and PD-L1 Drug Production by Region (2024-2029) & (K Units)
Table 8. World PD-1 and PD-L1 Drug Production Market Share by Region (2018-2023)
Table 9. World PD-1 and PD-L1 Drug Production Market Share by Region (2024-2029)
Table 10. World PD-1 and PD-L1 Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World PD-1 and PD-L1 Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. PD-1 and PD-L1 Drug Major Market Trends
Table 13. World PD-1 and PD-L1 Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World PD-1 and PD-L1 Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World PD-1 and PD-L1 Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World PD-1 and PD-L1 Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key PD-1 and PD-L1 Drug Producers in 2022
Table 18. World PD-1 and PD-L1 Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key PD-1 and PD-L1 Drug Producers in 2022
Table 20. World PD-1 and PD-L1 Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global PD-1 and PD-L1 Drug Company Evaluation Quadrant
Table 22. World PD-1 and PD-L1 Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and PD-1 and PD-L1 Drug Production Site of Key Manufacturer
Table 24. PD-1 and PD-L1 Drug Market: Company Product Type Footprint
Table 25. PD-1 and PD-L1 Drug Market: Company Product Application Footprint
Table 26. PD-1 and PD-L1 Drug Competitive Factors
Table 27. PD-1 and PD-L1 Drug New Entrant and Capacity Expansion Plans
Table 28. PD-1 and PD-L1 Drug Mergers & Acquisitions Activity
Table 29. United States VS China PD-1 and PD-L1 Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China PD-1 and PD-L1 Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China PD-1 and PD-L1 Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based PD-1 and PD-L1 Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PD-1 and PD-L1 Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers PD-1 and PD-L1 Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers PD-1 and PD-L1 Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers PD-1 and PD-L1 Drug Production Market Share (2018-2023)
Table 37. China Based PD-1 and PD-L1 Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PD-1 and PD-L1 Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers PD-1 and PD-L1 Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers PD-1 and PD-L1 Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers PD-1 and PD-L1 Drug Production Market Share (2018-2023)
Table 42. Rest of World Based PD-1 and PD-L1 Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers PD-1 and PD-L1 Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers PD-1 and PD-L1 Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers PD-1 and PD-L1 Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers PD-1 and PD-L1 Drug Production Market Share (2018-2023)
Table 47. World PD-1 and PD-L1 Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World PD-1 and PD-L1 Drug Production by Type (2018-2023) & (K Units)
Table 49. World PD-1 and PD-L1 Drug Production by Type (2024-2029) & (K Units)
Table 50. World PD-1 and PD-L1 Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World PD-1 and PD-L1 Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World PD-1 and PD-L1 Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World PD-1 and PD-L1 Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World PD-1 and PD-L1 Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World PD-1 and PD-L1 Drug Production by Application (2018-2023) & (K Units)
Table 56. World PD-1 and PD-L1 Drug Production by Application (2024-2029) & (K Units)
Table 57. World PD-1 and PD-L1 Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World PD-1 and PD-L1 Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World PD-1 and PD-L1 Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World PD-1 and PD-L1 Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 62. Bristol Myers Squibb Major Business
Table 63. Bristol Myers Squibb PD-1 and PD-L1 Drug Product and Services
Table 64. Bristol Myers Squibb PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bristol Myers Squibb Recent Developments/Updates
Table 66. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 67. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Merck & Co., Inc. Major Business
Table 69. Merck & Co., Inc. PD-1 and PD-L1 Drug Product and Services
Table 70. Merck & Co., Inc. PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck & Co., Inc. Recent Developments/Updates
Table 72. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 73. F. Hoffmann -La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 74. F. Hoffmann -La Roche Ltd Major Business
Table 75. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product and Services
Table 76. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. F. Hoffmann -La Roche Ltd Recent Developments/Updates
Table 78. F. Hoffmann -La Roche Ltd Competitive Strengths & Weaknesses
Table 79. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 80. AstraZeneca Major Business
Table 81. AstraZeneca PD-1 and PD-L1 Drug Product and Services
Table 82. AstraZeneca PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. AstraZeneca Recent Developments/Updates
Table 84. AstraZeneca Competitive Strengths & Weaknesses
Table 85. Sanofi Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Major Business
Table 87. Sanofi PD-1 and PD-L1 Drug Product and Services
Table 88. Sanofi PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Recent Developments/Updates
Table 90. Sanofi Competitive Strengths & Weaknesses
Table 91. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 92. Pfizer Inc Major Business
Table 93. Pfizer Inc PD-1 and PD-L1 Drug Product and Services
Table 94. Pfizer Inc PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Pfizer Inc Recent Developments/Updates
Table 96. Pfizer Inc Competitive Strengths & Weaknesses
Table 97. Lilly Basic Information, Manufacturing Base and Competitors
Table 98. Lilly Major Business
Table 99. Lilly PD-1 and PD-L1 Drug Product and Services
Table 100. Lilly PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Lilly Recent Developments/Updates
Table 102. Lilly Competitive Strengths & Weaknesses
Table 103. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 104. Novartis AG Major Business
Table 105. Novartis AG PD-1 and PD-L1 Drug Product and Services
Table 106. Novartis AG PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Novartis AG Recent Developments/Updates
Table 108. Novartis AG Competitive Strengths & Weaknesses
Table 109. GSK Basic Information, Manufacturing Base and Competitors
Table 110. GSK Major Business
Table 111. GSK PD-1 and PD-L1 Drug Product and Services
Table 112. GSK PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. GSK Recent Developments/Updates
Table 114. GSK Competitive Strengths & Weaknesses
Table 115. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 116. Junshi Biosciences Major Business
Table 117. Junshi Biosciences PD-1 and PD-L1 Drug Product and Services
Table 118. Junshi Biosciences PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Junshi Biosciences Recent Developments/Updates
Table 120. Junshi Biosciences Competitive Strengths & Weaknesses
Table 121. Akeso, Inc Basic Information, Manufacturing Base and Competitors
Table 122. Akeso, Inc Major Business
Table 123. Akeso, Inc PD-1 and PD-L1 Drug Product and Services
Table 124. Akeso, Inc PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Akeso, Inc Recent Developments/Updates
Table 126. Akeso, Inc Competitive Strengths & Weaknesses
Table 127. BeiGene Basic Information, Manufacturing Base and Competitors
Table 128. BeiGene Major Business
Table 129. BeiGene PD-1 and PD-L1 Drug Product and Services
Table 130. BeiGene PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. BeiGene Recent Developments/Updates
Table 132. BeiGene Competitive Strengths & Weaknesses
Table 133. Innovent Basic Information, Manufacturing Base and Competitors
Table 134. Innovent Major Business
Table 135. Innovent PD-1 and PD-L1 Drug Product and Services
Table 136. Innovent PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Innovent Recent Developments/Updates
Table 138. Innovent Competitive Strengths & Weaknesses
Table 139. Jiangsu Hengrui Medicine Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 140. Jiangsu Hengrui Medicine Co.,Ltd Major Business
Table 141. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product and Services
Table 142. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Jiangsu Hengrui Medicine Co.,Ltd Recent Developments/Updates
Table 144. Jiangsu Hengrui Medicine Co.,Ltd Competitive Strengths & Weaknesses
Table 145. Cstone Basic Information, Manufacturing Base and Competitors
Table 146. Cstone Major Business
Table 147. Cstone PD-1 and PD-L1 Drug Product and Services
Table 148. Cstone PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Cstone Recent Developments/Updates
Table 150. Cstone Competitive Strengths & Weaknesses
Table 151. Henlius Basic Information, Manufacturing Base and Competitors
Table 152. Henlius Major Business
Table 153. Henlius PD-1 and PD-L1 Drug Product and Services
Table 154. Henlius PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Henlius Recent Developments/Updates
Table 156. Simcere Pharmaceutical Group Limited Basic Information, Manufacturing Base and Competitors
Table 157. Simcere Pharmaceutical Group Limited Major Business
Table 158. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product and Services
Table 159. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of PD-1 and PD-L1 Drug Upstream (Raw Materials)
Table 161. PD-1 and PD-L1 Drug Typical Customers
Table 162. PD-1 and PD-L1 Drug Typical Distributors
Table 1. World PD-1 and PD-L1 Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World PD-1 and PD-L1 Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World PD-1 and PD-L1 Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World PD-1 and PD-L1 Drug Production Value Market Share by Region (2018-2023)
Table 5. World PD-1 and PD-L1 Drug Production Value Market Share by Region (2024-2029)
Table 6. World PD-1 and PD-L1 Drug Production by Region (2018-2023) & (K Units)
Table 7. World PD-1 and PD-L1 Drug Production by Region (2024-2029) & (K Units)
Table 8. World PD-1 and PD-L1 Drug Production Market Share by Region (2018-2023)
Table 9. World PD-1 and PD-L1 Drug Production Market Share by Region (2024-2029)
Table 10. World PD-1 and PD-L1 Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World PD-1 and PD-L1 Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. PD-1 and PD-L1 Drug Major Market Trends
Table 13. World PD-1 and PD-L1 Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World PD-1 and PD-L1 Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World PD-1 and PD-L1 Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World PD-1 and PD-L1 Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key PD-1 and PD-L1 Drug Producers in 2022
Table 18. World PD-1 and PD-L1 Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key PD-1 and PD-L1 Drug Producers in 2022
Table 20. World PD-1 and PD-L1 Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global PD-1 and PD-L1 Drug Company Evaluation Quadrant
Table 22. World PD-1 and PD-L1 Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and PD-1 and PD-L1 Drug Production Site of Key Manufacturer
Table 24. PD-1 and PD-L1 Drug Market: Company Product Type Footprint
Table 25. PD-1 and PD-L1 Drug Market: Company Product Application Footprint
Table 26. PD-1 and PD-L1 Drug Competitive Factors
Table 27. PD-1 and PD-L1 Drug New Entrant and Capacity Expansion Plans
Table 28. PD-1 and PD-L1 Drug Mergers & Acquisitions Activity
Table 29. United States VS China PD-1 and PD-L1 Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China PD-1 and PD-L1 Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China PD-1 and PD-L1 Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based PD-1 and PD-L1 Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PD-1 and PD-L1 Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers PD-1 and PD-L1 Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers PD-1 and PD-L1 Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers PD-1 and PD-L1 Drug Production Market Share (2018-2023)
Table 37. China Based PD-1 and PD-L1 Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PD-1 and PD-L1 Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers PD-1 and PD-L1 Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers PD-1 and PD-L1 Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers PD-1 and PD-L1 Drug Production Market Share (2018-2023)
Table 42. Rest of World Based PD-1 and PD-L1 Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers PD-1 and PD-L1 Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers PD-1 and PD-L1 Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers PD-1 and PD-L1 Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers PD-1 and PD-L1 Drug Production Market Share (2018-2023)
Table 47. World PD-1 and PD-L1 Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World PD-1 and PD-L1 Drug Production by Type (2018-2023) & (K Units)
Table 49. World PD-1 and PD-L1 Drug Production by Type (2024-2029) & (K Units)
Table 50. World PD-1 and PD-L1 Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World PD-1 and PD-L1 Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World PD-1 and PD-L1 Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World PD-1 and PD-L1 Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World PD-1 and PD-L1 Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World PD-1 and PD-L1 Drug Production by Application (2018-2023) & (K Units)
Table 56. World PD-1 and PD-L1 Drug Production by Application (2024-2029) & (K Units)
Table 57. World PD-1 and PD-L1 Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World PD-1 and PD-L1 Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World PD-1 and PD-L1 Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World PD-1 and PD-L1 Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 62. Bristol Myers Squibb Major Business
Table 63. Bristol Myers Squibb PD-1 and PD-L1 Drug Product and Services
Table 64. Bristol Myers Squibb PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bristol Myers Squibb Recent Developments/Updates
Table 66. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 67. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Merck & Co., Inc. Major Business
Table 69. Merck & Co., Inc. PD-1 and PD-L1 Drug Product and Services
Table 70. Merck & Co., Inc. PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck & Co., Inc. Recent Developments/Updates
Table 72. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 73. F. Hoffmann -La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 74. F. Hoffmann -La Roche Ltd Major Business
Table 75. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product and Services
Table 76. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. F. Hoffmann -La Roche Ltd Recent Developments/Updates
Table 78. F. Hoffmann -La Roche Ltd Competitive Strengths & Weaknesses
Table 79. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 80. AstraZeneca Major Business
Table 81. AstraZeneca PD-1 and PD-L1 Drug Product and Services
Table 82. AstraZeneca PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. AstraZeneca Recent Developments/Updates
Table 84. AstraZeneca Competitive Strengths & Weaknesses
Table 85. Sanofi Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Major Business
Table 87. Sanofi PD-1 and PD-L1 Drug Product and Services
Table 88. Sanofi PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Recent Developments/Updates
Table 90. Sanofi Competitive Strengths & Weaknesses
Table 91. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 92. Pfizer Inc Major Business
Table 93. Pfizer Inc PD-1 and PD-L1 Drug Product and Services
Table 94. Pfizer Inc PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Pfizer Inc Recent Developments/Updates
Table 96. Pfizer Inc Competitive Strengths & Weaknesses
Table 97. Lilly Basic Information, Manufacturing Base and Competitors
Table 98. Lilly Major Business
Table 99. Lilly PD-1 and PD-L1 Drug Product and Services
Table 100. Lilly PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Lilly Recent Developments/Updates
Table 102. Lilly Competitive Strengths & Weaknesses
Table 103. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 104. Novartis AG Major Business
Table 105. Novartis AG PD-1 and PD-L1 Drug Product and Services
Table 106. Novartis AG PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Novartis AG Recent Developments/Updates
Table 108. Novartis AG Competitive Strengths & Weaknesses
Table 109. GSK Basic Information, Manufacturing Base and Competitors
Table 110. GSK Major Business
Table 111. GSK PD-1 and PD-L1 Drug Product and Services
Table 112. GSK PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. GSK Recent Developments/Updates
Table 114. GSK Competitive Strengths & Weaknesses
Table 115. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 116. Junshi Biosciences Major Business
Table 117. Junshi Biosciences PD-1 and PD-L1 Drug Product and Services
Table 118. Junshi Biosciences PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Junshi Biosciences Recent Developments/Updates
Table 120. Junshi Biosciences Competitive Strengths & Weaknesses
Table 121. Akeso, Inc Basic Information, Manufacturing Base and Competitors
Table 122. Akeso, Inc Major Business
Table 123. Akeso, Inc PD-1 and PD-L1 Drug Product and Services
Table 124. Akeso, Inc PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Akeso, Inc Recent Developments/Updates
Table 126. Akeso, Inc Competitive Strengths & Weaknesses
Table 127. BeiGene Basic Information, Manufacturing Base and Competitors
Table 128. BeiGene Major Business
Table 129. BeiGene PD-1 and PD-L1 Drug Product and Services
Table 130. BeiGene PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. BeiGene Recent Developments/Updates
Table 132. BeiGene Competitive Strengths & Weaknesses
Table 133. Innovent Basic Information, Manufacturing Base and Competitors
Table 134. Innovent Major Business
Table 135. Innovent PD-1 and PD-L1 Drug Product and Services
Table 136. Innovent PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Innovent Recent Developments/Updates
Table 138. Innovent Competitive Strengths & Weaknesses
Table 139. Jiangsu Hengrui Medicine Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 140. Jiangsu Hengrui Medicine Co.,Ltd Major Business
Table 141. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product and Services
Table 142. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Jiangsu Hengrui Medicine Co.,Ltd Recent Developments/Updates
Table 144. Jiangsu Hengrui Medicine Co.,Ltd Competitive Strengths & Weaknesses
Table 145. Cstone Basic Information, Manufacturing Base and Competitors
Table 146. Cstone Major Business
Table 147. Cstone PD-1 and PD-L1 Drug Product and Services
Table 148. Cstone PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Cstone Recent Developments/Updates
Table 150. Cstone Competitive Strengths & Weaknesses
Table 151. Henlius Basic Information, Manufacturing Base and Competitors
Table 152. Henlius Major Business
Table 153. Henlius PD-1 and PD-L1 Drug Product and Services
Table 154. Henlius PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Henlius Recent Developments/Updates
Table 156. Simcere Pharmaceutical Group Limited Basic Information, Manufacturing Base and Competitors
Table 157. Simcere Pharmaceutical Group Limited Major Business
Table 158. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product and Services
Table 159. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of PD-1 and PD-L1 Drug Upstream (Raw Materials)
Table 161. PD-1 and PD-L1 Drug Typical Customers
Table 162. PD-1 and PD-L1 Drug Typical Distributors
LIST OF FIGURES
Figure 1. PD-1 and PD-L1 Drug Picture
Figure 2. World PD-1 and PD-L1 Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World PD-1 and PD-L1 Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World PD-1 and PD-L1 Drug Production (2018-2029) & (K Units)
Figure 5. World PD-1 and PD-L1 Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World PD-1 and PD-L1 Drug Production Value Market Share by Region (2018-2029)
Figure 7. World PD-1 and PD-L1 Drug Production Market Share by Region (2018-2029)
Figure 8. North America PD-1 and PD-L1 Drug Production (2018-2029) & (K Units)
Figure 9. Europe PD-1 and PD-L1 Drug Production (2018-2029) & (K Units)
Figure 10. China PD-1 and PD-L1 Drug Production (2018-2029) & (K Units)
Figure 11. Japan PD-1 and PD-L1 Drug Production (2018-2029) & (K Units)
Figure 12. PD-1 and PD-L1 Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 15. World PD-1 and PD-L1 Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 17. China PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 22. India PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of PD-1 and PD-L1 Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for PD-1 and PD-L1 Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for PD-1 and PD-L1 Drug Markets in 2022
Figure 26. United States VS China: PD-1 and PD-L1 Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: PD-1 and PD-L1 Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: PD-1 and PD-L1 Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers PD-1 and PD-L1 Drug Production Market Share 2022
Figure 30. China Based Manufacturers PD-1 and PD-L1 Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers PD-1 and PD-L1 Drug Production Market Share 2022
Figure 32. World PD-1 and PD-L1 Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World PD-1 and PD-L1 Drug Production Value Market Share by Type in 2022
Figure 34. PD-1 Monoclonal Antibody
Figure 35. PD-L1 Monoclonal Antibody
Figure 36. World PD-1 and PD-L1 Drug Production Market Share by Type (2018-2029)
Figure 37. World PD-1 and PD-L1 Drug Production Value Market Share by Type (2018-2029)
Figure 38. World PD-1 and PD-L1 Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World PD-1 and PD-L1 Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World PD-1 and PD-L1 Drug Production Value Market Share by Application in 2022
Figure 41. Liver Cancer
Figure 42. Esophageal Cancer
Figure 43. Nasal Cancer
Figure 44. Stomach Cancer
Figure 45. Other
Figure 46. World PD-1 and PD-L1 Drug Production Market Share by Application (2018-2029)
Figure 47. World PD-1 and PD-L1 Drug Production Value Market Share by Application (2018-2029)
Figure 48. World PD-1 and PD-L1 Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. PD-1 and PD-L1 Drug Industry Chain
Figure 50. PD-1 and PD-L1 Drug Procurement Model
Figure 51. PD-1 and PD-L1 Drug Sales Model
Figure 52. PD-1 and PD-L1 Drug Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. PD-1 and PD-L1 Drug Picture
Figure 2. World PD-1 and PD-L1 Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World PD-1 and PD-L1 Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World PD-1 and PD-L1 Drug Production (2018-2029) & (K Units)
Figure 5. World PD-1 and PD-L1 Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World PD-1 and PD-L1 Drug Production Value Market Share by Region (2018-2029)
Figure 7. World PD-1 and PD-L1 Drug Production Market Share by Region (2018-2029)
Figure 8. North America PD-1 and PD-L1 Drug Production (2018-2029) & (K Units)
Figure 9. Europe PD-1 and PD-L1 Drug Production (2018-2029) & (K Units)
Figure 10. China PD-1 and PD-L1 Drug Production (2018-2029) & (K Units)
Figure 11. Japan PD-1 and PD-L1 Drug Production (2018-2029) & (K Units)
Figure 12. PD-1 and PD-L1 Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 15. World PD-1 and PD-L1 Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 17. China PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 22. India PD-1 and PD-L1 Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of PD-1 and PD-L1 Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for PD-1 and PD-L1 Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for PD-1 and PD-L1 Drug Markets in 2022
Figure 26. United States VS China: PD-1 and PD-L1 Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: PD-1 and PD-L1 Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: PD-1 and PD-L1 Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers PD-1 and PD-L1 Drug Production Market Share 2022
Figure 30. China Based Manufacturers PD-1 and PD-L1 Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers PD-1 and PD-L1 Drug Production Market Share 2022
Figure 32. World PD-1 and PD-L1 Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World PD-1 and PD-L1 Drug Production Value Market Share by Type in 2022
Figure 34. PD-1 Monoclonal Antibody
Figure 35. PD-L1 Monoclonal Antibody
Figure 36. World PD-1 and PD-L1 Drug Production Market Share by Type (2018-2029)
Figure 37. World PD-1 and PD-L1 Drug Production Value Market Share by Type (2018-2029)
Figure 38. World PD-1 and PD-L1 Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World PD-1 and PD-L1 Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World PD-1 and PD-L1 Drug Production Value Market Share by Application in 2022
Figure 41. Liver Cancer
Figure 42. Esophageal Cancer
Figure 43. Nasal Cancer
Figure 44. Stomach Cancer
Figure 45. Other
Figure 46. World PD-1 and PD-L1 Drug Production Market Share by Application (2018-2029)
Figure 47. World PD-1 and PD-L1 Drug Production Value Market Share by Application (2018-2029)
Figure 48. World PD-1 and PD-L1 Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. PD-1 and PD-L1 Drug Industry Chain
Figure 50. PD-1 and PD-L1 Drug Procurement Model
Figure 51. PD-1 and PD-L1 Drug Sales Model
Figure 52. PD-1 and PD-L1 Drug Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
